News

The following six biosimilars were given a positive opinion at the June meeting: treatments for treatment of age-related macular degeneration and visual impairment: Mynzepli (aflibercept), and its ...
The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.
By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...
Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...
Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.
BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...
The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...
The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...